Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interferon Alpha Therapy for Cervical CIN I and HPV Infection

NCT06137950 is registered in ClinicalTrials.gov with Mongolian National University of Medical Sciences as lead sponsor.

NCT NCT06137950
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06137950 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interferon Alpha Therapy for Cervical CIN I and HPV Infection
Lead sponsor
Mongolian National University of Medical Sciences
Phase
Phase 1
Overall status
Completed
Start date
November 7, 2023
Completion date
March 31, 2025
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical dysplasia, hpv infection